A detailed history of China Universal Asset Management Co., Ltd. transactions in 23and Me Holding Co. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 65,297 shares of ME stock, worth $199,808. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65,297
Previous 38,012 71.78%
Holding current value
$199,808
Previous $14,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$0.29 - $0.51 $7,912 - $13,915
27,285 Added 71.78%
65,297 $22,000
Q2 2024

Jul 19, 2024

SELL
$0.36 - $0.61 $8,150 - $13,811
-22,641 Reduced 37.33%
38,012 $14,000
Q1 2024

Apr 29, 2024

BUY
$0.4 - $0.91 $9,841 - $22,389
24,604 Added 68.25%
60,653 $32,000
Q4 2023

May 21, 2024

SELL
$0.71 - $0.97 $17,468 - $23,865
-24,604 Reduced 40.57%
36,049 $32,000
Q4 2023

Jan 23, 2024

BUY
$0.71 - $0.97 $20,042 - $27,382
28,229 Added 360.98%
36,049 $33,000
Q3 2023

May 21, 2024

BUY
$0.96 - $2.01 $3,819 - $7,997
3,979 Added 103.59%
7,820 $7,000
Q3 2023

Oct 30, 2023

BUY
$0.96 - $2.01 $3,819 - $7,997
3,979 Added 103.59%
7,820 $8,000
Q2 2023

May 21, 2024

SELL
$1.59 - $2.29 $112 - $162
-71 Reduced 1.81%
3,841 $6,000
Q2 2023

Jul 27, 2023

SELL
$1.59 - $2.29 $112 - $162
-71 Reduced 1.81%
3,841 $7,000
Q1 2023

May 21, 2024

BUY
$2.05 - $2.87 $2,047 - $2,867
999 Added 34.29%
3,912 $8,000
Q1 2023

Apr 27, 2023

BUY
$2.05 - $2.87 $2,047 - $2,867
999 Added 34.29%
3,912 $9,000
Q4 2022

May 21, 2024

SELL
$2.06 - $3.47 $118,944 - $200,357
-57,740 Reduced 95.2%
2,913 $6,000
Q4 2022

Jan 31, 2023

BUY
$2.06 - $3.47 $990 - $1,669
481 Added 19.78%
2,913 $6,000
Q3 2022

Oct 21, 2022

BUY
$2.6 - $5.12 $6,323 - $12,451
2,432 New
2,432 $7,000

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $795M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.